We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The U.S. FDA and the Centers for Disease Control and Prevention (CDC) have updated their alert on sanofi pasteur's meningococcal vaccine Menactra after additional reports surfaced of patients suffering from Guillain-Barre Syndrome (GBS) shortly after receiving the drug.
Bayer HealthCare and Topsun Science and Technology Co. announced that Bayer's Consumer Care Division has signed an agreement in China to acquire the Western OTC cough and cold drug portfolio of Topsun's Qidong Gaitianli Pharmaceutical for approximately 103 million euros plus contingent payments of approximately 19 million euros subject to fulfillment of certain performance criteria.
A polio immunization campaign scheduled for early November in Kenya has gained urgency with the identification of a case of the paralyzing disease in a camp for refugees from Somalia, Kenya's Ministry of Health told UN Integrated Regional Information Networks (IRIN).
A U.S. appeals court has denied Ranbaxy's petition to rehear its August decision in a patent case involving atorvastatin, the active ingredient in Lipitor, according to Pfizer.
The European Medicines Agency (EMEA) has concluded its review of non-selective non-steroidal anti-inflammatory drugs (NSAIDs) and found that the benefit-risk balance for is favorable.
Researchers with Japan-based Daiichi Sankyo have presented data from a Phase I study in which a 60-mg loading dose of the company's investigational antiplatelet compound prasugrel showed faster onset of activity and achieved greater inhibition of platelet aggregation than either the approved 300-mg loading dose of Plavix (clopidogrel) or a higher 600-mg Plavix dose.
Zimbabwe's government has been forced to hold off treating more HIV-positive people amid reports that antiretroviral (ARV) drug supplies could run out by December, reports UN Integrated Regional Information Networks (IRIN).
The World Health Organization (WHO) has released a new Global Action Plan to increase pandemic influenza vaccine supply that requires immediate action and funding from developed countries, and the U.S. and Canada have already promised to help.
The UK's National Institute for Health and Clinical Excellence (NICE) is currently appraising the use of Millennium Pharmaceutical's Velcade (bortezomib) for the treatment of multiple myeloma.